Dolby Laboratories, Inc. (DLB) CEO Sells $1,138,847.20 in Stock

Dolby Laboratories, Inc. (NYSE:DLB) CEO Kevin J. Yeaman sold 18,548 shares of the company’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $61.40, for a total transaction of $1,138,847.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Kevin J. Yeaman also recently made the following trade(s):

  • On Monday, February 12th, Kevin J. Yeaman sold 68,548 shares of Dolby Laboratories stock. The stock was sold at an average price of $59.66, for a total transaction of $4,089,573.68.
  • On Thursday, February 8th, Kevin J. Yeaman sold 50,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $61.32, for a total transaction of $3,066,000.00.
  • On Thursday, February 8th, Kevin J. Yeaman sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.33, for a total transaction of $6,233,000.00.
  • On Monday, December 18th, Kevin J. Yeaman sold 11,130 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.47, for a total transaction of $695,291.10.
  • On Tuesday, December 19th, Kevin J. Yeaman sold 17,590 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.45, for a total transaction of $1,098,495.50.

Shares of Dolby Laboratories, Inc. (DLB) traded up $0.10 during trading hours on Tuesday, hitting $62.52. 462,133 shares of the company were exchanged, compared to its average volume of 445,869. The stock has a market cap of $6,470.00, a P/E ratio of 99.24, a P/E/G ratio of 5.07 and a beta of 0.78. Dolby Laboratories, Inc. has a 52 week low of $48.00 and a 52 week high of $74.29.

Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings results on Wednesday, January 24th. The electronics maker reported $0.79 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.44 by $0.35. The company had revenue of $287.80 million for the quarter, compared to the consensus estimate of $265.75 million. Dolby Laboratories had a net margin of 6.06% and a return on equity of 12.02%. The firm’s quarterly revenue was up 8.1% on a year-over-year basis. During the same period in the previous year, the firm earned $0.66 EPS. analysts anticipate that Dolby Laboratories, Inc. will post 0.99 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 14th. Shareholders of record on Monday, February 5th will be issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 1.02%. The ex-dividend date of this dividend is Friday, February 2nd. Dolby Laboratories’s dividend payout ratio (DPR) is presently 101.59%.

DLB has been the topic of a number of research analyst reports. B. Riley reissued a “buy” rating and issued a $65.50 price target on shares of Dolby Laboratories in a report on Thursday, October 26th. Zacks Investment Research downgraded shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Wednesday, January 3rd. Finally, JPMorgan Chase & Co. boosted their price target on shares of Dolby Laboratories from $63.00 to $70.00 and gave the stock a “neutral” rating in a report on Thursday, January 25th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the stock. Dolby Laboratories presently has an average rating of “Hold” and a consensus target price of $62.00.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Intl Fcstone Inc. purchased a new stake in Dolby Laboratories during the second quarter valued at about $345,000. Schroder Investment Management Group purchased a new stake in Dolby Laboratories during the third quarter valued at about $35,761,000. Dimensional Fund Advisors LP lifted its holdings in Dolby Laboratories by 0.5% during the second quarter. Dimensional Fund Advisors LP now owns 536,657 shares of the electronics maker’s stock valued at $26,276,000 after purchasing an additional 2,648 shares during the last quarter. Highbridge Capital Management LLC purchased a new stake in Dolby Laboratories during the third quarter valued at about $254,000. Finally, Wells Fargo & Company MN lifted its holdings in Dolby Laboratories by 6.0% during the third quarter. Wells Fargo & Company MN now owns 629,039 shares of the electronics maker’s stock valued at $36,183,000 after purchasing an additional 35,558 shares during the last quarter. 52.74% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: This report was reported by American Banking News and is owned by of American Banking News. If you are viewing this report on another site, it was copied illegally and republished in violation of United States and international copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2018/02/13/dolby-laboratories-inc-dlb-ceo-sells-1138847-20-in-stock.html.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply